quinazolines has been researched along with Toxoplasmosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HJ; Nam, HW; Park, YH; Yang, Z | 1 |
| Allegra, CJ; Chabner, BA; Drake, JC; Kovacs, JA; Masur, H; Swan, JC | 1 |
2 other study(ies) available for quinazolines and Toxoplasmosis
| Article | Year |
|---|---|
Afatinib Reduces STAT6 Signaling of Host ARPE-19 Cells Infected with Toxoplasma gondii.
Topics: Afatinib; Antiparasitic Agents; Blotting, Western; Cell Line; Enzyme Activation; Fluorescent Antibody Technique; Humans; Janus Kinase 1; Janus Kinase 3; Phosphorylation; Quinazolines; Signal Transduction; STAT6 Transcription Factor; Toxoplasma; Toxoplasmosis | 2016 |
Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate.
Topics: Animals; Folic Acid Antagonists; Kinetics; Lacticaseibacillus casei; Mice; Mice, Inbred BALB C; Quinazolines; Solubility; Toxoplasma; Toxoplasmosis; Trimetrexate | 1987 |